|
Originally published In Press as doi:10.1074/jbc.M101935200 on May 16, 2001
J. Biol. Chem., Vol. 276, Issue 31, 29361-29367, August 3, 2001
Individual Rotavirus-like Particles Containing 120 Molecules of Fluorescent Protein Are Visible in Living
Cells*,
Annie
Charpilienne ,
Mohamed
Nejmeddine §,
Mabel
Berois ,
Nathalie
Parez¶,
Emmanuelle
Neumann ,
Elizabeth
Hewat ,
Germain
Trugnan§, and
Jean
Cohen **
From Virologie Moléculaire et Cellullaire,
INRA, 78352 Jouy-en-Josas, Cedex, France, § INSERM
U538, Faculté de Médecine Saint-Antoine, 27 rue de
Chaligny, 75571 Paris, Cedex 12, France, ¶ Laboratoire de
Virologie, Hôpital Armand Trousseau (EA 2391, UFR Saint-Antoine),
Paris, France, and Laboratoire de Microscopie Electronique
Structurale, Institut de Biologie Structurale, 41 rue Jules Horowitz,
38027 Grenoble, Cedex 1, France
Received for publication, March 2, 2001, and in revised form, May 11, 2001
 |
ABSTRACT |
Rotaviruses are large, complex icosahedral
particles consisting of three concentric capsid layers. When the
innermost capsid protein VP2 is expressed in the baculovirus-insect
cell system it assembles as core-like particles. The amino terminus
region of VP2 is dispensable for assembly of virus-like particles
(VLP). Coexpression of VP2 and VP6 produces double layered VLP.
We hypothesized that the amino end of VP2 could be extended without
altering the auto assembly properties of VP2. Using the green
fluorescent protein (GFP) or the DsRed protein as model inserts we have
shown that the chimeric protein GFP (or DsRed)-VP2 auto assembles
perfectly well and forms fluorescent VLP (GFP-VLP2/6 or DsRed-VLP2/6)
when coexpressed with VP6. The presence of GFP inside the core does not
prevent the assembly of the outer capsid layer proteins VP7 and VP4 to
give VLP2/6/7/4. Cryo-electron microscopy of purified GFP-VLP2/6 showed
that GFP molecules are located at the 5-fold vertices of the core. It
is possible to visualize a single fluorescent VLP in living cells by
confocal fluorescent microscopy. In vitro VLP2/6 did not
enter into permissive cells or in dendritic cells. In contrast,
fluorescent VLP2/6/7/4 entered the cells and then the fluorescence
signal disappear rapidly. Presented data indicate that fluorescent VLP
are interesting tools to follow in real time the entry process of
rotavirus and that chimeric VLP could be envisaged as "nanoboxes"
carrying macromolecules to living cells.
 |
INTRODUCTION |
The rotaviruses, members of the family Reoviridae, are the most
important cause of severe viral gastroenteritis in humans and animals.
Morphologically and biochemically, the capsid consists of three
concentric layers. The outermost layer in the infectious virus is
composed of the glycoprotein VP7 and the hemagglutinin spike protein
VP4. The intermediate capsid layer is composed of trimers of VP6
organized on a T = 13 icosahedral lattice (1). The innermost
capsid layer is composed of 120 molecules of a 102-kDa protein (VP2)
and encloses the genomic dsRNA (2). VP2 binds to viral RNA, and its
nucleic acid binding domain is located between amino acids
(aa)1 1 and 132 (3). The bond
between Gln-92 and Lys-93 in VP2 is a protease-accessible site (4). It
has been shown that coexpression of capsid viral proteins in the
baculovirus system results in the assembly of virus-like particles
(VLP) (2). Depending on the set of expressed proteins several types of
VLP are obtained (5). VLP are stable, and when they include the spike
protein, they share several properties with infectious virus including cell binding, sarcine coentry, activation of NF- B, and cell fusion from without (5-8).
Because they provide a safe antigen delivery system, various
particulate carrier systems using viral proteins have been constructed and analyzed for their immunogenicity (9-11). In general molecules carried by VLP are small (12, 13), and the inserted epitope domain is
grafted outside the VLP. However, three chimeric VLP have been
constructed with exceptionally large inserts; they are papillomavirus
VLP containing E7 and E2 of the same virus (14), parvovirus B19 with
hen egg white lysozyme presented at the capsid surface (15), and
hepatitis B VLP with green fluorescent protein (GFP) inserted on
an external loop (16). To our knowledge a limited number of native
virus particles have been conjugated by chemical grafting to a
fluorescent dye including reovirus (17) and influenza virus (18). These
labeled virions exhibit a decrease in their specific infectivity but
can be visualized in living cells.
In the rotavirus model, the amino terminus region of VP2 is dispensable
for assembly of VLP, and the deletion of the first 92 amino acids of
VP2 resulted in the formation of pseudo-core particles ( 92VLP2).
Complexes of the two enzymes VP1 and VP3, which are involved in the
transcription of the genome within the intact particle, are anchored to
the inner surface of VP2 at the icosahedral vertices (19). Analysis of
92VLP2 suggests that the amino termini are clustered around the 12 icosahedral vertices, with the RNA binding domains facing inward (20).
On this basis we reasoned that the addition of a large protein domain
at the amino terminus could fit into the space occupied by the VP1-VP3 complex and by the genome in the virus particle. We hypothesized that
the addition of much larger inserts than those previously added to
chimeric VLP might be tolerated. Accordingly, we prepared two chimeric
VP2 in which amino acids 1-92 are replaced either by the entire 238-aa
GFP or by the entire 249-aa DsRed protein (21), both followed by a
flexible linker. This addition did not affect assembly of double and
triple layered VLP. Moreover a single VLP can be detected by
fluorescent microscopy. This is the first report of VLP with a long
exogenous polypeptide enclosed within. These chimeric particles allow
to study the first steps of rotavirus infection.
 |
EXPERIMENTAL PROCEDURES |
Plasmid and Recombinant Baculovirus Constructs--
The plasmid
pBS2C24 (22), constructed for the expression of VP2 with the first
92 amino acids deleted, was modified to remove the extra methionine.
The linker TCTAGAGGATCC was added to provide an XbaI site
and a flexible linker, consisting of the amino acids SRGS between VP2
and the fused protein. This fragment was then subcloned in pVL1392
(Invitrogen) and the recombinant plasmid named pVL1392JA16. The GFP
gene was recovered from pEGFPC1 (CLONTECH) and
ligated into pVL1392JA16. Recombinant plasmids were sequenced to
determine the integrity of the GFP insert and of the linker. The
recombinant clone containing the GFP in the proper orientation was
named pVLJA16PEGFPC1. Similarly, DsRed fluorescent protein that
consists of 249 residues (28 kDa) (CLONTECH) (23)
(21) was fused to 92VP2, but the transfer vector was pFastbac
instead of pVL1392.
To generate the recombinant baculovirus expressing GFP fused to
92VP2, a mixture of 2 µg of purified transfer vector DNA plus 500 ng of linearized parental baculovirus DNA AcRP6SC (24) was added to
Spodoptera frugiperda clone 9 (Sf9) insect cells in
the presence of the transfection reagent. The recombinant baculovirus expressing DsRed- 92VP2 was obtained with the Bac to Bac system (Life
Technologies, Inc.) Recombinant baculoviruses were plaque-purified, and
selected viruses were referred to as GFPJA16 and DsRedJA16.
Preparation of VLP2/6, 92VLP2/6 or fluorescent VLP2/6, and
VLP2/6/7/4--
Four different VLP containing full-length VP2 and VP6
(VLP2/6), 92VP2 and VP6 ( 92VLP2/6), GFP- 92VP2 and VP6
(GFP-VLP2/6), or DsRed- 92VP2 and VP6 (DsRed-VLP2/6) were produced in
the baculovirus expression system as described earlier (2). Briefly
Sf9 cells were coinfected with two baculoviruses expressing VP6
and an authentic or a modified VP2 at a multiplicity of infection
higher than 5 plaque-forming units/cell, collected 5-7 days
post-infection, and then treated with Freon 113, purified by density
gradient centrifugation in CsCl. The concentration of protein in the
purified VLP suspension was estimated by the method of Bradford using
bovine serum albumin as standard. Usually the final preparation
has a concentration of ~1 mg/ml. Because the calculated molecular
weight of GFP-VLP2/6 is 5 × 107, a 1-mg/ml
suspension contains 1.2 × 1013 particles/ml.
Coinfections with recombinant baculovirus expressing GFP- 92VP2, VP6,
VP7 (BVP7 A459RD; see Ref. 25), and VP4 (BVP4 expressing the VP4 of the
bovine strain RF)2
produced three layered particles with VP4 spikes (GFP-VLP2/6/7/4) and
were purified by the same method.
Confocal Microscopy--
Confocal microscopic analysis was
carried out using the TCS SP1 confocal imaging system (Leica
Instruments, Heidelberg, Germany), equipped with a × 63 objective
(numerical aperture = 1.4). The signal was integrated over
four to eight frames to reduce the noise. For calibration purpose we
used FluoSpheres® carboxylate-modified red fluorescent microspheres,
0.1 µm (2.7 × 1013 particles/ml), purchased from
Molecular Probes Europe BV, Leiden, The Netherlands.
For visualization of VLP entry a mixture of DsRed-VLP2/6 and
trypsinized GFP-VLP2/6/7/4 was absorbed on MA104 cells for 30 min at
4 °C, washed with serum-free medium, shifted for various time
lengths at 37 °C, and finally fixed with 2% para-formaldehyde. Untrypsinized GFP-VLP2/6/7/4 were used in control experiments. Time
lapse experiments were carried out on human dendritic cells prepared as
described (26) and generously provided by J. C. Gluckman (INSERM, EMI
00-13, Hôpital Saint-Antoine, Paris). They were used after
48 h of granulocyte macrophage-colony stimulating factor
treatment to promote a dendritic differentiation. VLP-GFP (either
VLP2/6 or VLP2/6/7/4) were added to the cells at time zero, together
with 0.1 µm of red FluoSpheres®. To control their ability to enter
the cells, GFP-VLP were trypsinized (1 µg/ml for 15 min at room
temperature) before addition. Time lapse capture was performed using
the software provided by Leica (Scanware, Version 1.6.587). At each
time, 5 sections, 0.5 mm each, encompassing the whole depth of the
cells, were recorded with two consecutive accumulated passes during
which both the green and the red channel were captured, together with
the transmitted light. Cells were recorded every 30 s for a total
duration of 30 min. The five sections of each channel (green and
red) at each time were projected to give an image that corresponds to
the sum of all the volume at a given time. The resulting data were
animated using NIH image software (version 1.6.1).
Electron Microscopy--
Specimens for electron microscopy were
prepared from the appropriate CsCl gradient fractions containing
GFP-VLP2/6 or VLP2/6. For cryo-electron microscopy frozen hydrated
specimens were prepared on holy carbon grids as described
previously (27). Samples of the VLP suspension were applied to grids,
blotted immediately with filter paper for 1-2 s, and rapidly plunged
into liquid ethane. Specimens were photographed at a temperature of
close to 180 °C using a Gatan 626 cryo-holder in a Phillips CM200
operating at 200 kV. Defocus image pairs were obtained under low dose
conditions (<10 electrons/Å2) at a nominal
magnification of × 38,000 at underfocus values ranging from 0.7 to 2.5 µm.
Image Analysis--
Micrographs were digitized using an Optonics
microdensitometer with a pixel size of 12.5 µm corresponding to a
nominal pixel size of 4.30 Å. Image analysis was performed on a
Silicon Graphic Incorporated using the ICOS program suite (28).
The common lines method (29) was used for the initial determination of
particle origins and orientations in the VLP2/6 micrograph. The polar
Fourier transform model-based method (30) was used for all subsequent orientation and origin determinations for both reconstructions. The
VLP2/6 reconstruction was computed to 18 Å using 76 particles, and the
GFP-VLP2/6 reconstruction was computed to 19 Å using 79 particles.
Only information before the first zero of the contrast transfer
function was used. Fourier ring correlation was used to estimate the
resolution (31).
Protein Analysis and Native Agarose Gel Electrophoresis--
For
SDS-PAGE analysis (12.5% polyacrylamide, 0.1% SDS) the Laemmli system
(32) was used, and proteins were detected by Coomassie Blue staining.
Aliquots from CsCl gradient fractions were loaded onto 0.8% (w/v.)
agarose gels in MOPS-Tris buffer, pH 6.6, and were run at 5 V/cm (33).
Nucleic acids and GFP-VLP were visualized by illumination at 310 nm.
Immunization with GFP-VLP2/6--
For immunization, 100 µg of
CsCl gradient-purified GFP-VLP2/6 were injected twice (days 0 and 21)
intraperitoneally into mice with Freund's adjuvant. The final serum
was collected 7 days after the boost and assayed on COS-7 cells
transfected with pEGFPC1 plasmid by indirect immunofluorescence using
Alexa 588-labeled anti-mice secondary antibody.
 |
RESULTS |
Design of the Chimeric VLP and Expression of GFP-VP2 Fusion Protein
in Insect Cells--
For demonstrating the feasibility of rotavirus
"nanoboxes" we constructed chimeric VLP that assemble as well as
normal VLP and contain 120 copies of a functional protein inside the
VLP, fused to VP2. GFP appeared to be an ideal model insert, because its fluorescence depends on proper folding. To minimize steric constraints, an SRGS linker was added at the carboxyl end of GFP. After
electrophoretic analysis and Coomassie Blue staining, visible bands of
apparent molecular masses of 80, 92, and 110 kDa were detected
in the extracts of Sf9 cells infected with recombinant baculovirus expressing 92VP2, VP2, and GFP- 92, respectively (Fig.
1, lanes 2-4). The apparent
molecular weight of the band observed in cell infected with
GFPJA16 baculovirus corresponds to the expected size for the chimeric
92VP2 protein fused to GFP. This was confirmed by immunoblotting
with an anti-VP2 monoclonal and a commercial anti-GFP serum (data not
shown).

View larger version (59K):
[in this window]
[in a new window]
|
Fig. 1.
Expression of the fusion protein
GFP- 92VP2 in insect cells. Proteins
present in 5 × 104 Sf9 cells infected with
wild type baculovirus (1), recombinant baculoviruses
expressing 92 VP2 (2), VP2 (3), and
GFP- 92VP2 (4), were analyzed by PAGE and stained by
Coomassie Blue. Were also analyzed by PAGE CsCl gradient-purified
VLP2/6 (5) and GFP-VLP2/6 (6). Positions of
molecular weight markers are indicated on the
left.
|
|
Efficient Assembly of Fluorescent VLP--
To test for the
assembly of VLP made of chimeric VP2, we coexpressed GFP- 92VP2 or
DsRed- 92VP2 with VP6 and purified the possible VLP by density
gradient centrifugation. As shown in Fig. 2 bands corresponding to 92VLP2/6 and
fluorescent VLP2/6 were similar when illuminated with white light, but
only bands corresponding to GFP-VLP (or DsRed-VLP) were visible under
UV light. As determined by PAGE, the CsCl gradient band contained VP6
and either GFP-VP2 or VP2 (Fig. 1, lanes 5 and 6)
or VP6 and DsRed-VP2 (not shown). The stoichiometry of VP6 and the
chimeric VP2 (or authentic VP2) was similar in all types of VLP and in
virus particles. Electron microscopy of negatively stained (not shown)
and frozen hydrated preparations revealed the presence of
morphologically identical VLP in gradients (Fig.
3).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 2.
Purification of GFP or DsRed protein
containing VLP. Sf9 cells were infected with both
recombinant baculoviruses containing the gene 6 of VP6 and either the
recombinant baculovirus expressing the 92VP2 (1 and
3) or the chimeric GFP- 92VP2 (2 and
4) or the chimeric DsRed- 92VP2 (5 and
6) and treated with Freon 113 as described under
"Experimental Procedures." After 18 h of centrifugation at
35,000 rpm the tubes were illuminated with white light (1,
2, and 6) or with a hand-held UV lamp
(3, 4, and 5) and photographed.
|
|

View larger version (155K):
[in this window]
[in a new window]
|
Fig. 3.
Cryo-electron micrographs of frozen hydrated
rotavirus VLP2/6 (A) and GFP-VLP2/6
(B). The scale bar represents 20 nm.
|
|
The assembly was also tested, by comparing the electrophoretic
migration in native agarose gels of GFP-VLP2/6 and authentic VLP2/6
with viral double layered particles (DLP) and triple layered particles
(TLP). The RNA present in DLP and TLP was stained red with ethidium
bromide, and it was possible to visualize a green-colored band
corresponding to GFP-VLP (Fig. 4). In
this electrophoresis system the migration rate depend on the size and
on the charge of the objects (thus on the presence of RNA in DLP).
Because DLP and VLP2/6 have the same diameter the green band migrated
close to the band corresponding to DLP.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 4.
Analysis of various rotavirus particles by
native agarose gel electrophoresis. Purified TLP, DLP, GFP-VLP2/6,
and VLP2/6 were submitted to electrophoresis in 0.6% agarose. The gel
was stained with ethidium bromide and photographed.
|
|
Spectrophotometry measurements were performed to evaluate the proper
folding of the inserted GFP molecules. We measured the absorbency at
488 nm of purified GFP (CLONTECH) and purified
GFP-VLP, and we calculated the molar extinction coefficient. As
expected native GFP exhibits a strong absorbency in the visible range
with a maximum at 488 nm and a molar extinction coefficient of
EM = 53000 M 1·cm 1 (34). The extinction
coefficients of GFP-VLP at 488 nm varied between
EM =50600 and 55250 M 1·cm 1. This result indicated
that all GFP molecules (120 molecules per VLP) contained the authentic
chromophore and that spacing between the GFP chromophores had no
quenching effects. Hence, at least 95% of the GFP domains in the
particulate chimeric protein are properly folded.
The Inserted GFP Is Located in the Interior of
VLP--
Cryo-electron micrographs of GFP-VLP2/6 and VLP2/6 are
indistinguishable by eye (Fig. 3), and their three-dimensional
reconstructions reveal an identical morphology seen from the outside
(Fig. 5, A and B).
However, differences are visible in the interior of the capsid on and
around the 5-fold icosahedral axes. In the GFP-VLP2/6 density map there
is additional density compared with the VLP2/6 map inside the capsid on
each of the 5-fold axes (Fig. 5C). Also there are
five zones of missing density roughly 7 nm from the 5-fold axis (Fig.
5, D-F). Difference maps between GFP-VLP2/6 and VLP2/6 show
that these differences are well above the noise level. It is now well
established from cryo-electron microscopy of rotavirus (20) and
orthoreovirus (35), and the crystallographic structure of the core of
bluetongue virus (36), that the VP2 (or the VP2 equivalent) of all
these viruses are arranged as 60 dimers on a T = 1 icosahedral
lattice. The amino termini of each VP2 of the dimer are located inside
the capsid with one very close to the 5-fold axis and the second at a
distance roughly 7 nm from the 5-fold axis. Thus we are able to
interpret the missing density in the GFP-VLP2/6 as the missing 92 amino
acids. This is in agreement with the difference maps of 92VLP2/6 and
VLP2/6 determined by Prasad and colleagues (20). We interpret the
additional density on the 5-fold as representing five GFP molecules
that are only partially ordered and thus only partially visible.

View larger version (110K):
[in this window]
[in a new window]
|
Fig. 5.
Isosurface representations of the rotavirus
VLP2/6 (A) and GFPVLP2/6 (B),
reconstructed to a resolution of 18 and 19 Å, respectively. The
icosahedral axes are marked in A. C shows 50-Å
thick central sections of GFPVLP2/6 (top) and VLP2/6
(bottom). The VP6 is shaded in blue, the VP2 in
gray, and the GFP in green in A,
B, and C. The reconstructions are viewed down a
2-fold axis. Close-up views down the 5-fold axis of rotavirus VLP2/6
(D) and GFPVLP2/6 (E) viewed from inside the
capsid are shown. The difference map between GFPVLP2/6 and VLP2/6
(F) shows the site of the missing 92 aa shaded
pink (negative difference) and the GFP in purple
(positive difference). The scale bar in C
represents 10 nm for A, B, and C, the
bar represents 2 nm in D, E, and
F.
|
|
Chimeric GFP-VLP Particles Effectively Elicit Antibodies against
Native GFP--
VP2 is located inside the virus particle and inside
the VLP; however, immunization with VLP2/6 induces a clear antibody
response to VP2 (37). To test the ability of the chimeric particles to induce antibodies against native GFP, mice were immunized with the
purified particles. Preimmune and hyperimmune sera were tested by
indirect immunofluorescence on COS cells transfected with a plasmid
containing the gene of GFP under the control of the cytomegalovirus promoter. Diluted hyperimmune serum revealed by an Alexa-conjugated anti-mouse antiserum lead to a clear staining of cells expressing GFP
(Fig. 6).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 6.
Efficient induction of anti-GFP antibody by
GFPVLP2/6. Serum raised against purified GFPVLP2/6 was used for
immunostaining of COS cells transfected with pEGFPC. A,
detection of GFP by direct fluorescence; B, cells were
incubated with the serum raised against GFPVLP2/6 at a 1/1000 dilution
and later with Alexa 588-conjugated anti-mouse for immunodetection. The
same immunostaining with the preimmune serum revealed no fluorescence
signal (not shown). The bar represents 10 µm.
|
|
Microscopy of Fluorescent VLP--
With a standard microscope,
observation of a 1 mg/ml suspension of fluorescent VLP revealed faint
spots that looked like stars in the Milky Way (not shown). At the
confocal microscope level, the detection of GFP-VLP (or DsRed-VLP) was
much easier, and individual green (or red) spots could be identified
(Fig. 7A). Increasing the
illumination intensity made the individual spot brighter but did not
reveal new spots. This suggested that each spot corresponds to a single
VLP and that sources dimmer than a single VLP spot were not present.
The intensity of spots was fairly homogenous with some exceptions that
could correspond to small aggregates. To confirm that most of the spots
corresponded to a single VLP we observed a mix of 100 nm in diameter
red fluorescent latex beads and GFP-VLP. The concentration of latex
beads and VLP were both adjusted to 3.109/ml. It appeared
that the number of red and green spots was of the same magnitude (Fig.
7B). Assuming that beads and VLP bind as efficiently on the
glass this confirmed that most of the green spots corresponded to a
single VLP. Addition of antibody to GFP-VLP lead to specific
aggregation depending on the nature of the outer protein of the VLP;
GFP-VLP2/6 and GFP-VLP2/6/7/4 are aggregated by RV138 and 7/7 directed
against VP6 and VP4, respectively (Fig. 7, C-F).

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 7.
Visualization of individual VLP.
Purified GFPVLP2/6 at 1 mg/ml were diluted to 1/10000 and directly
examined in a confocal microscope (A) or mixed with latex
beads diluted to 1/10000 (B). Arrows indicate
putative small aggregates of VLP. GFP-VLP2/6 (C and
D) and GFP-VLP2/6/7/4 (E and F) were
examined by confocal microscopy either alone (C and
E) or agglutinated after addition of specific antibodies Mab
RV138 (anti-VP6; D) or Mab 7/7 (anti-VP4;
F).
|
|
Entry of Fluorescent VLP into Living Cells--
It has been shown
previously that VLP containing the spike protein VP4 bind to permissive
cells (5). To examine whether fluorescent VLP were also competent for
entry, we first incubated MA104 cells with a mix of DsRed-VLP2/6 and
GFP-VLP2/6/7/4. After 30 min of adsorption at 4 °C, cells were
washed, shifted to 37 °C, and further incubated for 15 or 30 min to
allow the penetration of VLP. When GFP-VLP2/6/7/4 were not trypsinized
(Fig. 8A) both types of VLP
were retained at the cell surfaces as confirmed by vertical x-z
section (Fig. 8B). In contrast with trypsinized
GFP-VLP2/6/7/4, the green signal strongly decreased indicating that
these VLP entered the cells, whereas DsRed-VLP2/6 were still detected
at the cell surface (Fig. 8, C and D). It could
be noted that despite extensive washing, fluorescent DsRed-VLP2/6 that
do not present the viral attachment protein (VP4) remained at the cell
surface.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 8.
Interactions of VLP2/6 and VLP2/6/7/4
with MA104. Cells were incubated at 4 °C for 30 min with a
mixture of DsRed-VLP2/6 (A-D) and nontrypsinized
GFP-VLP2/6/7/4 (A and B) or trypsinized
GFP-VLP2/6/7/4 (C and D), shifted to 37 °C and
further incubated for 15 min. 10 0.5-µm depth sections were collected
and projected (horizontal projection) to give images
A and C. The same fields were analyzed directly
by x-z scanning (B and D). Before the shift to
37 °C localization of trypsinized was similar to localization of
nontrypsinized GFP-VLP2/6/7/4. The distribution of nontrypsinized
GFP-VLP2/6/7/4 did not change during the shift to 37 °C.
|
|
To explore the interactions between VLP and professional
antigen-presenting cells we incubated VLP with living human dendritic cells (at room temperature) for 30 min, and images were recorded every
30 s. A majority of nontrypsinized GFP-VLP2/6/7/4 were not internalized during the experiment (not shown). When trypsinized GFP-VLP2/6/7/4 were used, two main phenomenons were observed. As shown
on Fig. 9 (and in the video that can be
downloaded at http://www.jbc.org), some VLP seemed to move along
extensions of dendritic cells toward the cell body. They appeared to
roll on the cell surface, as confirmed by the analysis of individual sections, which showed that these VLP were present on the outermost optical sections. In the meantime, other VLP, associated with the cell
body surface from the beginning of the experiment, move less actively
and seemed to disappear after 15 min, suggesting that they are rapidly
internalized.

View larger version (181K):
[in this window]
[in a new window]
|
Fig. 9.
Time lapse analysis of fluorescent VLP with
dendritic cells. Human dendritic cells were incubated for 15 min
at 4 °C with trypsinized GFP-VLP2/6/7/4 and 0.1 µm of red latex
beads and then switched to room temperature under the microscope. Time
lapse series were recorded as described under "Experimental
Procedures." After processing the series 4 time points were selected.
Arrows point to remarkable particles, and
arrowheads point to latex beads.
|
|
 |
DISCUSSION |
Presented data show that it is possible to fuse a protein to the
amino terminus of rotavirus VP2 deleted of the first 92 amino acids,
without altering the autoassembly property of VP2. Particles that we
obtained have the same diameter as authentic VLP, and their outer
surface is not modified, because VP6 assembles on the modified VP2
particles as well as it assembles on the native VP2. After addition of
VP6, the outer layer of the viral capsid consisting of VP7 and VP4 can
also assemble.
The production of fluorescent particles indicates that the individual
constituents of the chimeric protein are properly folded, because both
particle formation and fluorescence depend on a native three-dimensional structure. Direct evidence for the formation of
capsid-like particles containing GFP was obtained by cryo-electron microscopy and image reconstruction, revealing the presence of particles with the same T = 1 and T = 13 architecture as
observed previously for authentic VLP (19, 20). Using difference map analysis to compare structures of GFP-VLP2/6 and VLP2/6 we have defined
the probable locations of the GFP within the core. The GFP molecules
are only partially visible on the 5-fold axis and not at the expected
positions off axis. The 4-aa flexible linker apparently allows the GFP
to move about quite freely, which means that they are lost in the
averaging inherent in the three-dimensional reconstruction except on
5-fold axis where they have restricted movement because of the close
proximity of the five on axis GFP.
Whereas the insertion of small peptides into virus and virus-like
particles is a long established practice, the insertion capacity
appeared to be limited (13), because long inserts appear to affect
folding of capsid proteins. For example when the hepatitis B virus
preS2 region (amino acid residues 1-48) is fused upstream to, and
collinear with, the amino terminus of bluetongue virus VP7 protein
(preS2-VP7) core assembly is possible only if a fraction of this
protein is chimeric, the outer shell being a mixture of normal and
chimeric molecules of VP7 (38). Two types of VLP, derived from
hepatitis B virus core and from papillomavirus, have been
amenable to large addition or insertion. For HBV core particles, the
exogenous protein (GFP) is inserted into the 76-83 loop and is
surface-exposed (16). Papillomavirus VLP containing E7 or E2 proteins
from the same virus are more comparable with the VLP described here,
because extra polypeptides correspond to entire proteins and project
into the interior of the empty capsid (14). Our study demonstrates that
a complete foreign protein of about 250 aa can be present in multiple
copies inside a chimeric rotavirus capsid. The connection between GFP
and VP2 must not sterically hinder formation of the final structure.
Apparently, the flexible linker at the end of GFP meets this
requirement. Hence, we believe that the native display of other
proteins (or protein domains) of the size of GFP and possibly larger
can be accomplished. This view is supported by preliminary evidence
showing that addition of chameleon GFP (643-aa-long; see Ref. 39), a
fragment of the F protein of respiratory syncytial virus (261 aa), and
VP8* of rotavirus (241 aa) do not inhibit particle formation.
An intriguing perspective for structural studies is that proteins fused
inside rotavirus VLP might become amenable to high-resolution cryo-electron microscopy analyses. This possibility was investigated for the hepatitis B virus VLP with a GFP insert on the outside of the
capsid (16). In the hepatitis B VLP construction, GFP was inserted at
the tip of the external spike with two linking regions. In that case
GFP was clearly visible in the cryo-EM images, but the
three-dimensional reconstruction revealed that GFP was only partially
ordered. Optimizing the flanking linker sequences to allow rigid fixing
of the foreign protein domains to the surface such that they adopt well
defined positions while allowing normal VLP formation is clearly the
key to this approach.
One of the major interests of fluorescent rotavirus VLP is to enable
the first direct observation of VLP interactions with living cells.
Indeed we were able to follow in real time the internalization of
fluorescent VLP on two cell types, namely human dendritic and monkey
MA104 cells. In addition we were able to compare in the same experiment
the fate of entry-competent (trypsinized VLP2/6/7/4; green) and
entry-incompetent (VLP2/6; red) particles. Surprisingly, shortly after
entry, trypsinized VLP 2/6/7/4 were no longer detectable. This could be
because of either the fact that the internalized particles reached an
acidic compartment in which fluorescence was quenched (endosomes and/or
lysosomes) (34) and/or because of the disruption of the VLP into
smaller objects not detectable at the optical microscope level. It has
been shown previously that VP2 is completely inside VLP2/6 (20) and
that immunization of mice with VLP2/6 induces antibodies against VP2
(37). It is thus not surprising that the chimeric particles efficiently induced antibodies against native epitopes of the protein graft located
inside the VLP. This suggests that both chimeric and authentic VLP
present their inner components to the immune system following degradation that occurs after inoculation. One advantage of rotavirus VLP as a transport system is their ability to enter target cells through the recognition of host cell receptors followed by specific viral uptake mechanisms (5).
In conclusion, we demonstrated the possibility of producing recombinant
chimeric rotavirus VLP with a properly folded protein within. Addition
of the outer capsid proteins is possible, and therefore, such complete
VLP imitate natural viruses and could be used as a transport system for
cell-specific drug delivery. Several approaches have been investigated
to improve the oral bioavailability of bioactive peptides and proteins.
Among them, the use of VLP delivery systems represents a promising
concept, particularly when VLP are derived from a virus of the
gastrointestinal tract. Packaging peptides and proteins in particles
should provide added protection of these molecules against degradation
and, in some cases, also enhance their absorption. Other specific
applications of the fluorescent VLP might be to follow the
intracellular trafficking of authentic VLP or virus and also to trace
the fate of virus particles in the environment after administration to
a complete organism.
 |
ACKNOWLEDGEMENTS |
We thank Philippe Fontanges for assistance
withthe confocal microscopy work, Cynthia Jaeger for technical
help, and J. C. Gluckman for providing purified dendritic
cells. We also thank D. Poncet, C. Sapin, and A. Garbarg-Chenon for
critically reading the manuscript.
 |
FOOTNOTES |
*
This work was supported by a Programme de Reherche
Fondamentale en Microbiologie, sur les Maladies Infectieuses et
Parasitaires grant (148-2000) from Ministere de l'EN seignement de la
Recherche et de la Technologie, a grant from Action Concertée
Initiative Microbiologie (1A029F), an Innovation Technique et
Methodologique grant (4TM06F) from INSERM, and a 5th Programme Cadre de
Recherche et Developpement grant from Union Européenne (QLRT
1999-00634).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The on-line version of this article (available at
http://www.jbc.org) contains a movie corresponding to
the whole sequence of GFP-VLP entry in dendritic cell (Fig. 9).
**
To whom correspondence should be addressed. Tel.: 33-0-1-3465-2604;
Fax: 33-0-1-3465-2621; E-mail: cohen@jouy.inra.fr.
Published, JBC Papers in Press, May 16, 2001, DOI 10.1074/jbc.M101935200
2
J. Cohen, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
aa, amino acid(s);
VLP, virus-like particle(s);
GFP, green fluorescent protein;
Sf9, Spodoptera frugiperda clone 9;
PAGE, polyacrylamide gel electrophoresis;
MOPS, 4-morpholinepropanesulfonic
acid;
DLP, double layered particles;
TLP, triple layered
particles.
 |
REFERENCES |
| 1.
|
Prasad, B. V.,
Wang, G. J.,
Clerx, J. P.,
and Chiu, W.
(1988)
J. Mol. Biol.
199,
269-275
|
| 2.
|
Labbé, M.,
Charpilienne, A.,
Crawford, S. E.,
Estes, M. K.,
and Cohen, J.
(1991)
J. Virol.
65,
2946-2952
|
| 3.
|
Labbé, M.,
Baudoux, P.,
Charpilienne, A.,
Poncet, D.,
and Cohen, J.
(1994)
J. Gen. Virol.
75,
3423-3430
|
| 4.
|
Zeng, C. Q.,
Labbe, M.,
Cohen, J.,
Prasad, B. V.,
Chen, D.,
Ramig, R. F.,
and Estes, M. K.
(1994)
Virology
201,
55-65
|
| 5.
|
Crawford, S. E.,
Labbé, M.,
Cohen, J.,
Burroughs, M. H.,
Zhou, Y. J.,
and Estes, M. K.
(1994)
J. Virol.
68,
5945-5922
|
| 6.
|
Gilbert, J. M.,
and Greenberg, H. B.
(1997)
J. Virol.
71,
4555-4563
|
| 7.
|
Liprandi, F.,
Moros, Z.,
Gerder, M.,
Ludert, J. E.,
Pujol, F. H.,
Ruiz, M. C.,
Michelangeli, F.,
Charpilienne, A.,
and Cohen, J.
(1997)
Virology
237,
430-438
|
| 8.
|
Rollo, E.,
Kumar, K.,
Reich, N.,
Cohen, J.,
Angel, J.,
Greenberg, H.,
Sheth, R.,
Anderson, J.,
Oh, B.,
Hempson, S.,
Mackow, E.,
and Shaw, R.
(1999)
J. Immunol.
163,
4442-4452
|
| 9.
|
Pearson, L. D.,
and Roy, P.
(1993)
Immunol. Cell Biol.
5,
381-389
|
| 10.
|
Laurent, S.,
Vautherot, J. F.,
Madelaine, M. F.,
Le Gall, G.,
and Rasschaert, D.
(1994)
J. Virol.
68,
6794-6798
|
| 11.
|
Ball, J. M.,
Estes, M. K.,
Hardy, M. E.,
Conner, M. E.,
Opekun, A. R.,
and Graham, D. Y.
(1996)
Arch. Virol.
12 Suppl. 12,
243-249
|
| 12.
|
Gilbert, S. C.,
Plebanski, M.,
Harris, S. J.,
Allsopp, C. E.,
Thomas, R.,
Layton, G. T.,
and Hill, A. V.
(1997)
Nat. Biotechnol.
15,
1280-1284
|
| 13.
|
Sedlik, C.,
Saron, M.,
Sarraseca, J.,
Casal, I.,
and Leclerc, C.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
7503-7508
|
| 14.
|
Greenstone, H. L.,
Nieland, J. D.,
de Visser, K. E.,
De Bruijn, M. L.,
Kirnbauer, R.,
Roden, R. B.,
Lowy, D. R.,
Kast, W. M.,
and Schiller, J. T.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
1800-1805
|
| 15.
|
Miyamura, K.,
Kajigaya, S.,
Momoeda, M.,
Smith-Gill, S. J.,
and Young, N. S.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
8507-8511
|
| 16.
|
Kratz, P. A.,
Bottcher, B.,
and Nassal, M.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
1915-1920
|
| 17.
|
Georgi, A.,
Mottola, H. C.,
Warner, A.,
Fields, B.,
and Chen, L. B.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
6579-6583
|
| 18.
|
Yoshimura, A.,
and Ohnishi, S.
(1984)
J. Virol.
51,
497-504
|
| 19.
|
Prasad, B. V.,
Rothnagel, R.,
Zeng, C. Q.,
Lawton, J. A.,
Chiu, W.,
and Estes, M. K.
(1996)
Nature
382,
471-473
|
| 20.
|
Lawton, J. A.,
Zeng, C. Q. Y.,
Mukherjee, S. K.,
Cohen, J.,
Estes, M. K.,
and Prasad, B. V. V.
(1997)
J. Virol.
71,
7353-7360
|
| 21.
|
Matz, M. V.,
Fradkov, A. F.,
Labas, Y. A.,
Savitsky, A. P.,
Zaraisky, A. G.,
Markelov, M. L.,
and Lukyanov, S. A.
(1999)
Nat. Biotechnol.
17,
969-973
|
| 22.
|
Zeng, C. Q. Y.,
Estes, M. K.,
Charpilienne, A.,
and Cohen, J.
(1998)
J. Virol.
72,
201-208
|
| 23.
|
Baird, G. S.,
Zacharias, D. A.,
and Tsien, R. Y.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
11984-11989
|
| 24.
|
Kitts, P. A.,
Ayres, M. D.,
and Possee, R. D.
(1990)
Nucleic Acids Res.
18,
5667
|
| 25.
|
Franco, M. A.,
Prieto, I.,
Labbe, M.,
Poncet, D.,
Borras-Cuesta, F.,
and Cohen, J.
(1993)
J. Gen. Virol.
74,
2579-2586
|
| 26.
|
Canque, B.,
Camus, S.,
Dalloul, A.,
Kahn, E.,
Yagello, M.,
Dezutter-Dambuyant, C.,
Schmitt, D.,
Schmitt, C.,
and Gluckman, J. C.
(2000)
Blood
96,
3748-3756
|
| 27.
|
Hewat, E. A.,
and Blaas, D.
(1996)
EMBO J.
15,
1515-1523
|
| 28.
|
Fuller, S. D.,
Butcher, S. J.,
Cheng, R. H.,
and Baker, T. S.
(1996)
J. Struct. Biol
116,
48-55
|
| 29.
|
Crowther, R. A.
(1971)
Philos. Trans. R. Soc. Lond. B. Biol. Sci.
261,
221-230
|
| 30.
|
Baker, T.,
and Cheng, R. H.
(1996)
J. Struct. Biol.
116,
120-130
|
| 31.
|
Saxton, W. O.,
and Baumeister, W.
(1982)
J. Microsci.
127,
127-138
|
| 32.
|
Laemmli, U.
(1970)
Nature
227,
680-685
|
| 33.
|
Ruiz, M. C.,
Charpilienne, A.,
Liprandi, F.,
Gajardo, R.,
Michelangeli, F.,
and Cohen, J.
(1996)
J. Virol.
70,
4877-4883
|
| 34.
|
Patterson, G. H.,
Knobel, S. M.,
Sharif, W. D.,
Kain, S. R.,
and Piston, D. W.
(1997)
Biophys. J.
73,
2782-2790
|
| 35.
|
Hill, C. L.,
Booth, T. F.,
Prasad, B. V.,
Grimes, J. M.,
Mertens, P. P.,
Sutton, G. C.,
and Stuart, D. I.
(1999)
Nat. Struct. Biol.
6,
565-568
|
| 36.
|
Grimes, J. M.,
Burroughs, J. N.,
Gouet, P.,
Diprose, J. M.,
Malby, R.,
Zientara, S.,
Mertens, P. P. C.,
and Stuart, D. I.
(1998)
Nature
395,
470-478
|
| 37.
|
O'Neal, C. M.,
Crawford, S. E.,
Estes, M. K.,
and Conner, M. E.
(1997)
J. Virol.
71,
8707-8717
|
| 38.
|
Belyaev, A. S.,
and Roy, P.
(1992)
Virology
190,
840-844
|
| 39.
|
Miyawaki, A.,
Griesbeck, O.,
Heim, R.,
and Tsien, R. Y.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
2135-2140
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Libersou, X. Siebert, M. Ouldali, L. F. Estrozi, J. Navaza, A. Charpilienne, P. Garnier, D. Poncet, and J. Lepault
Geometric Mismatches within the Concentric Layers of Rotavirus Particles: a Potential Regulatory Switch of Viral Particle Transcription Activity
J. Virol.,
March 15, 2008;
82(6):
2844 - 2852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bollenbach, P. Pantazis, A. Kicheva, C. Bokel, M. Gonzalez-Gaitan, and F. Julicher
Precision of the Dpp gradient
Development,
March 15, 2008;
135(6):
1137 - 1146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Dragestein, W. A. van Cappellen, J. van Haren, G. D. Tsibidis, A. Akhmanova, T. A. Knoch, F. Grosveld, and N. Galjart
Dynamic behavior of GFP-CLIP-170 reveals fast protein turnover on microtubule plus ends
J. Cell Biol.,
February 25, 2008;
180(4):
729 - 737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Di Martino, C. Basset, A. Ogier, A. Charpilienne, D. Poncet, and E. Kohli
Distribution and phenotype of rotavirus-specific B cells induced during the antigen-driven primary response to 2/6 virus-like particles administered by the intrarectal and the intranasal routes
J. Leukoc. Biol.,
October 1, 2007;
82(4):
821 - 828.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Goldsbury, E. Thies, S. Konzack, and E.-M. Mandelkow
Quantification of Amyloid Precursor Protein and Tau for the Study of Axonal Traffic Pathways
J. Neurosci.,
March 28, 2007;
27(13):
3357 - 3363.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Arnoldi, M. Campagna, C. Eichwald, U. Desselberger, and O. R. Burrone
Interaction of Rotavirus Polymerase VP1 with Nonstructural Protein NSP5 Is Stronger than That with NSP2
J. Virol.,
March 1, 2007;
81(5):
2128 - 2137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kicheva, P. Pantazis, T. Bollenbach, Y. Kalaidzidis, T. Bittig, F. Julicher, and M. Gonzalez-Gaitan
Kinetics of Morphogen Gradient Formation
Science,
January 26, 2007;
315(5811):
521 - 525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Schauss, J. Bewersdorf, and S. Jakobs
Fis1p and Caf4p, but not Mdv1p, determine the polar localization of Dnm1p clusters on the mitochondrial surface
J. Cell Sci.,
August 1, 2006;
119(15):
3098 - 3106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Das, D. Nayak, Y. Zhou, and A. K. Pattnaik
Visualization of intracellular transport of vesicular stomatitis virus nucleocapsids in living cells.
J. Virol.,
July 1, 2006;
80(13):
6368 - 6377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Feng, M. C. Jaimes, N. H. Lazarus, D. Monak, C. Zhang, E. C. Butcher, and H. B. Greenberg
Redundant Role of Chemokines CCL25/TECK and CCL28/MEC in IgA+ Plasmablast Recruitment to the Intestinal Lamina Propria After Rotavirus Infection
J. Immunol.,
May 15, 2006;
176(10):
5749 - 5759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Agnello, C. A. Herve, A. Lavaux, M. Darniot, P. Guillon, A. Charpilienne, and P. Pothier
Intrarectal Immunization with Rotavirus 2/6 Virus-Like Particles Induces an Antirotavirus Immune Response Localized in the Intestinal Mucosa and Protects against Rotavirus Infection in Mice.
J. Virol.,
April 1, 2006;
80(8):
3823 - 3832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Parez, C. Fourgeux, A. Mohamed, C. Dubuquoy, M. Pillot, A. Dehee, A. Charpilienne, D. Poncet, I. Schwartz-Cornil, and A. Garbarg-Chenon
Rectal Immunization with Rotavirus Virus-Like Particles Induces Systemic and Mucosal Humoral Immune Responses and Protects Mice against Rotavirus Infection
J. Virol.,
February 15, 2006;
80(4):
1752 - 1761.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Kar, N. Iwatani, and P. Roy
Assembly and Intracellular Localization of the Bluetongue Virus Core Protein VP3
J. Virol.,
September 1, 2005;
79(17):
11487 - 11495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Schlumberger, A. J. Muller, K. Ehrbar, B. Winnen, I. Duss, B. Stecher, and W.-D. Hardt
Real-time imaging of type III secretion: Salmonella SipA injection into host cells
PNAS,
August 30, 2005;
102(35):
12548 - 12553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Finke, K. Brzozka, and K.-K. Conzelmann
Tracking Fluorescence-Labeled Rabies Virus: Enhanced Green Fluorescent Protein-Tagged Phosphoprotein P Supports Virus Gene Expression and Formation of Infectious Particles
J. Virol.,
November 15, 2004;
78(22):
12333 - 12343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Parez, A. Garbarg-Chenon, C. Fourgeux, F. Le Deist, A. Servant-Delmas, A. Charpilienne, J. Cohen, and I. Schwartz-Cornil
The VP6 Protein of Rotavirus Interacts with a Large Fraction of Human Naive B Cells via Surface Immunoglobulins
J. Virol.,
November 15, 2004;
78(22):
12489 - 12496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Jaimes, O. L. Rojas, E. J. Kunkel, N. H. Lazarus, D. Soler, E. C. Butcher, D. Bass, J. Angel, M. A. Franco, and H. B. Greenberg
Maturation and Trafficking Markers on Rotavirus-Specific B Cells during Acute Infection and Convalescence in Children
J. Virol.,
October 15, 2004;
78(20):
10967 - 10976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Caballero, F. X. Abad, F. Loisy, F. S. Le Guyader, J. Cohen, R. M. Pinto, and A. Bosch
Rotavirus Virus-Like Particles as Surrogates in Environmental Persistence and Inactivation Studies
Appl. Envir. Microbiol.,
July 1, 2004;
70(7):
3904 - 3909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Berois, C. Sapin, I. Erk, D. Poncet, and J. Cohen
Rotavirus Nonstructural Protein NSP5 Interacts with Major Core Protein VP2
J. Virol.,
February 1, 2003;
77(3):
1757 - 1763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Schwartz-Cornil, Y. Benureau, H. Greenberg, B. A. Hendrickson, and J. Cohen
Heterologous Protection Induced by the Inner Capsid Proteins of Rotavirus Requires Transcytosis of Mucosal Immunoglobulins
J. Virol.,
July 17, 2002;
76(16):
8110 - 8117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Charpilienne, J. Lepault, F. Rey, and J. Cohen
Identification of Rotavirus VP6 Residues Located at the Interface with VP2 That Are Essential for Capsid Assembly and Transcriptase Activity
J. Virol.,
June 27, 2002;
76(15):
7822 - 7831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Chevalier, J. Lepault, I. Erk, B. Da Costa, and B. Delmas
The Maturation Process of pVP2 Requires Assembly of Infectious Bursal Disease Virus Capsids
J. Virol.,
March 1, 2002;
76(5):
2384 - 2392.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|